Literature DB >> 3977705

Botulinum A toxin injection as a treatment for blepharospasm.

A B Scott, R A Kennedy, H A Stubbs.   

Abstract

Thirty-nine patients with blepharospasm were treated with injections of botulinum A toxin into the lid and brow. The maximum number of injections in one patient was 16 over a period of 24 months. A reduction of abnormal movement occurred in all patients, lasting up to 170 days. Both the amount and the duration of effect were dose dependent. Reinjection for recurrence had effects similar to the original injection. Tearing, dry-eye symptoms, or transient ptosis occurred in 20% of injections, especially in patients who had had previous eyelid surgery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977705     DOI: 10.1001/archopht.1985.01050030043017

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  64 in total

1.  Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients.

Authors:  W Poewe; L Schelosky; B Kleedorfer; F Heinen; M Wagner; G Deuschl
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

Review 2.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

3.  Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm.

Authors:  P Roggenkämper; W H Jost; K Bihari; G Comes; S Grafe
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

4.  [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].

Authors:  P Roggenkämper
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

5.  Effects of botulinum A toxin injection on the extraocular muscle fiber layers: comparison between subtenon injection and intramuscular injection.

Authors:  Hae Jung Paik; Kui Dong Kang; Jin Seok Choi; Byung Gil Choi; Hye Bin Yim
Journal:  Jpn J Ophthalmol       Date:  2009-05-31       Impact factor: 2.447

6.  Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs.

Authors:  A R Bentivoglio; A Fasano; T Ialongo; F Soleti; S Lo Fermo; A Albanese
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

7.  Acute angle-closure glaucoma following botulinum toxin.

Authors: 
Journal:  Br J Ophthalmol       Date:  1991-06       Impact factor: 4.638

8.  Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy.

Authors:  Bettina Wabbels; Peter Roggenkämper
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07-28       Impact factor: 3.117

9.  Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease.

Authors:  J M Olver
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

10.  Botulinum toxin - From WMD to therapeutic agent and cosmetic aid.

Authors:  Roger M Pinder
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.